Matsumoto S, Yamasaki M, Kanno T, Nagayama T, Shimizu T
Department of Physiology, Fukushima Medical College, Japan.
Lung. 1993;171(1):1-13. doi: 10.1007/BF00177637.
We studied the effects of calcium channel antagonists (verapamil and nifedipine) and H1-receptor blockers (mequitazine) on changes in the slowly adapting pulmonary stretch receptors (SARs) located below the carina in response to right atrial injections of histamine (60 and 80 micrograms/kg) in anesthetized artificially ventilated rabbits with bilateral vagotomy. After histamine was injected into the right atrium, the SARs became more active during expiration but decreased their activity during inspiration. These changes were more pronounced by increasing the dosage of histamine. However, administration of histamine had no significant effect on tracheal pressure (PT). Verapamil treatment (1 mg/kg) did not alter the SAR response to histamine, whereas the responses of SARs to histamine at different dosages were significantly diminished by treatment with nifedipine (1 mg/kg). Mequitazine (1 mg/kg), a potent H1-receptor blocker, blocked completely all the responses of SAR activity to histamine. These results suggest that the effect of histamine 60-80 micrograms/kg on SAR activity is mediated by the activation of H1-receptors of the peripheral airway smooth muscle and that this activation, at least in part, involves the opening of calcium channels of the airway smooth muscle.
我们研究了钙通道拮抗剂(维拉帕米和硝苯地平)和H1受体阻滞剂(美喹他嗪)对麻醉状态下行双侧迷走神经切断术并人工通气的家兔隆突下方缓慢适应性肺牵张感受器(SARs)变化的影响,这些变化是在右心房注射组胺(60和80微克/千克)后出现的。向家兔右心房注射组胺后,SARs在呼气时变得更加活跃,但在吸气时活性降低。随着组胺剂量的增加,这些变化更加明显。然而,注射组胺对气管压力(PT)没有显著影响。维拉帕米治疗(1毫克/千克)并未改变SARs对组胺的反应,而硝苯地平(1毫克/千克)治疗则显著减弱了SARs对不同剂量组胺的反应。强效H1受体阻滞剂美喹他嗪(1毫克/千克)完全阻断了SAR活性对组胺的所有反应。这些结果表明,60 - 80微克/千克组胺对SAR活性的影响是由外周气道平滑肌H1受体的激活介导的,并且这种激活至少部分涉及气道平滑肌钙通道的开放。